What Losacor D Treats: Main Uses and Benefits

Losacor D is commonly used in therapeutic areas involving symptoms related to systemic imbalance and heightened physiological activity. This combination is commonly used in therapeutic contexts involving the management of high blood pressure (hypertension) to help ease the symptoms related to systemic imbalance. The medication is applied for conditions characterized by periods of heightened symptoms related to blood pressure, which may include sustained elevated systolic and diastolic readings, and is relevant for patients with hypertension who have Left Ventricular Hypertrophy (LVH).

This medication helps address symptom clusters that may become intense or disruptive due to multiple contributing factors, contributing to improved day-to-day comfort and stability in the management of blood pressure. It is generally applied in clinical scenarios when additional supportive symptom management is needed, supporting the overall goal of minimizing symptoms linked to organ-specific functional stress.

---

Quick Fact: Management of Elevated Blood Pressure

Therapeutic Benefits Summary

Losacor D is primarily used for the sustained management of chronic hypertension, and for Supportive Management in Cardiovascular Domains in specific patient groups. This approach contributes to the goal of long-term stabilization of blood pressure and supports easing the overall physiological strain associated with high pressure.

Regulatory References

1. NIH DailyMed Drug Labeling

The eligibility for Losacor D (Losartan/Hydrochlorothiazide) is strictly determined by regulatory contraindications and restrictions, primarily limiting use to the adult population without specific co-existing conditions.

Populations for Whom Use is Prohibited (Contraindicated)

Contraindicated Group	Restriction Basis
Pregnancy	Mandatory Discontinuation upon detection of pregnancy; Contraindicated during the 2nd and 3rd trimesters due to the high risk of fetal injury and death.
Hypersensitivity	Known allergy to losartan, any sulfonamide-derived medicines (like hydrochlorothiazide), or any other product component.
Severe Organ Impairment	Anuria (inability to pass urine), severe renal impairment (e.g., CrCl < 30 mL/min), or severe hepatic impairment (including cholestasis/biliary disorders).
Co-administration	Patients with diabetes or moderate-to-severe renal impairment who are also taking aliskiren (a direct renin inhibitor).

Restricted or Not-Recommended Use

• Pediatric Patients: The combination product is not recommended for use in children and adolescents under 18 years old due to insufficient data on safety and efficacy in this age group.
• Breastfeeding: Use is not recommended as hydrochlorothiazide passes into human milk, and losartan is present in animal milk; a decision must be made to stop the drug or stop nursing.
• Metabolic/Electrolyte Conditions: Contraindicated in cases of refractory hypokalemia (low potassium) and symptomatic gout.

Losacor D, a combination of losartan and hydrochlorothiazide, can interact with various medications and supplements, which may alter its effectiveness or increase the risk of side effects. It is essential to inform your doctor or pharmacist about all prescription, over-the-counter, and herbal products you are currently using.

Medications Requiring Special Caution

Certain combinations require close monitoring, dose adjustment, or should be avoided altogether due to increased risks such as severe drops in blood pressure (hypotension), elevated potassium levels (hyperkalemia), or kidney problems.

Drug Class / Product	Potential Interaction	Risk Level
Potassium-Sparing Diuretics (e.g., spironolactone, triamterene) or Potassium Supplements/Salt Substitutes	Significantly increased risk of hyperkalemia.	Major
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) (e.g., ibuprofen, naproxen, celecoxib)	May reduce the blood pressure-lowering effect and increase the risk of kidney damage, especially in dehydrated patients or the elderly.	Moderate to Major
Lithium (used for mental health conditions)	Can increase lithium levels in the blood, leading to toxicity.	Major
Other Blood Pressure Medicines (e.g., ACE inhibitors, aliskiren)	Increased risk of low blood pressure, high potassium, and kidney impairment (dual blockade).	Major

Other Important Interactions

• Cholestyramine or Colestipol: These may decrease the absorption of hydrochlorothiazide. Dosing should be separated by several hours.
• Alcohol: Consuming alcohol while on Losacor D may increase the risk of dizziness and low blood pressure.

Losacor D is a fixed-dose combination product containing losartan and hydrochlorothiazide, exerting its physiological effects through two distinct, complementary mechanisms.

Losartan, an Angiotensin II Receptor Blocker (ARB), and its active metabolite act as reversible, competitive antagonists at the Angiotensin II type 1 (AT1) receptor. These receptors are found in vascular smooth muscle, the adrenal gland, and other tissues. By blocking the binding of the active octapeptide Angiotensin II to the AT1 receptor, losartan prevents the Gq-mediated intracellular signaling cascade that normally leads to vasoconstriction and the release of aldosterone. The downstream consequence is a reduction in systemic vascular resistance and a decrease in sodium and water retention.

Hydrochlorothiazide is a thiazide diuretic that targets the renal tubules. It acts as an inhibitor of the sodium-chloride cotransporter (Na^+-Cl^- cotransporter) in the cortical diluting segment (distal convoluted tubule). This inhibition decreases the reabsorption of sodium (Na^+) and chloride (Cl^-) ions, leading to an increase in the renal excretion of Na^+, Cl^-, and water. The resulting reduction in plasma volume contributes to the overall systemic physiological modulation.

Losacor D (losartan potassium and hydrochlorothiazide) is a combination medication for high blood pressure and other cardiovascular indications, and must be taken exactly as prescribed by a healthcare provider.

General Administration Guidelines

• Timing: Take the tablet by mouth once daily, typically at the same time each day to maintain consistent drug levels in the body. It may be taken with or without food.
• Swallowing: Swallow the tablet whole. Do not crush, break, or chew the tablet.
• Missed Dose: If a dose is missed, take it as soon as you remember. If it is almost time for your next scheduled dose, skip the missed dose and resume your regular schedule. Do not take two doses at once to make up for a missed dose.
• Fluid Intake: Due to the hydrochlorothiazide component (a diuretic), this medication may cause increased urination. To prevent dehydration, drink adequate fluids unless otherwise directed by your doctor. Taking the dose at least four hours before bedtime may help avoid nighttime disruptions for urination.

Key Dosing Considerations

Patient Status	Typical Starting Dosage (Once Daily)	Maximum Recommended Dosage (Once Daily)
Adult Hypertension	50 mg Losartan / 12.5 mg HCTZ	100 mg Losartan / 25 mg HCTZ
Volume-Depleted Patients	A lower dose of losartan alone (25 mg) is typically considered first to correct volume depletion before initiating combination therapy.

Your prescribed dose is determined by your specific medical condition and response to therapy. Full blood pressure control may take between three and six weeks. Continue taking Losacor D even if you feel well, as high blood pressure often has no noticeable symptoms.

Losacor D: Recent Clinical Evidence

This section provides a factual summary of the clinical research conducted on the fixed-dose combination of Losartan and Hydrochlorothiazide, focusing on the available study structures and what they monitored.

---

Evidence in Essential Hypertension

Research evaluating this combination for high blood pressure was conducted primarily through Randomized Controlled Trials (RCTs). These studies monitored changes in systolic and diastolic blood pressure, as well as the proportion of participants measured within pre-defined blood pressure ranges. Findings describe observed patterns in these measurements, providing data related to understanding symptom patterns associated with chronic high blood pressure.

Research in High-Risk Conditions (LVH)

A large-scale, long-term Randomized Outcome Trial applied in the study of high blood pressure associated with Left Ventricular Hypertrophy (LVH). This research monitored the frequency of major cardiovascular events, including stroke and heart attack, over extended follow-up periods. Specific attention was given to changes measured in the incidence of stroke and the assessment of heart thickening (LVMI). The research highlights that results apply only to the populations studied and that patterns related to stroke may not apply equally to all patient subgroups.

Long-Term Data and Special Groups

The longest follow-up was observed in these outcome trials, averaging 4.8 years. However, long-term effects are not fully established for many outcomes in the general population. Research was evaluated in special groups, including those with Chronic Kidney Disease (CKD) and Metabolic Syndrome. Data for the pediatric population remains limited, and follow-up durations were limited in those specific studies. What is still uncertain includes a lack of comparative evidence against all other fixed-dose combinations for long-term cardiovascular outcomes.

Common questions about Losacor D (FAQ)

Q: How quickly should I expect Losacor D to start lowering blood pressure?

A: According to official product information, the blood pressure lowering effect is described as beginning within two hours of taking a dose. The maximum effect on blood pressure is typically assessed after three to six weeks of consistent daily use, as described in clinical study data.

Q: Does Losacor D cause a dry cough like some other blood pressure medicines?

A: Cough is listed as one of the common adverse reactions reported in clinical trials for the combination product. While this specific effect is often associated with a different class of blood pressure medicine (ACE inhibitors), cough is documented in the product information as a possible side effect.

Q: Is tiredness or fatigue a common side effect of Losacor D?

A: Regulatory labeling lists related effects such as dizziness as common, and somnolence (drowsiness) and malaise (general discomfort) as reported adverse experiences. Official documents note symptoms such as weakness and fatigue can be related to changes in blood pressure or electrolyte levels.

Q: Is it normal to feel dizzy when standing up while taking Losacor D?

A: The product information notes that dizziness is a common side effect and that low blood pressure (hypotension) may occur. The product information notes this type of positional dizziness may occur, particularly in patients who have volume or salt depletion.

Q: What are the most serious side effects I should know about Losacor D?

A: The product label includes serious warnings, such as the Black Box Warning regarding the risk of fetal injury or death if used during the second or third trimesters of pregnancy. It also highlights the risk of a severe allergic reaction, angioedema (swelling of the face, lips, and throat), and the potential for severe low blood pressure or worsening of certain conditions like kidney or liver problems.

Q: Can I drink coffee or caffeine while taking Losacor D?

A: Official labeling does not list a specific interaction with caffeine or coffee. Patient management guidelines related to high blood pressure often address the intake of substances that can temporarily affect blood pressure.

Q: Does Losacor D interact with pain relievers like ibuprofen or aspirin?

A: The combination is known to interact with Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), including common pain relievers like ibuprofen and aspirin. This combination is described as potentially reducing the blood pressure-lowering effect and increasing the potential risk of kidney function problems, particularly for patients who are dehydrated or elderly.

Q: Are there any foods or vitamins that interact with Losacor D?

A: The product labeling advises caution regarding products that affect potassium levels, specifically mentioning potassium supplements and salt substitutes that contain potassium. Additionally, some regulatory patient information sources advise caution with large amounts of grapefruit or grapefruit juice due to the potential to increase the levels of Losartan in the body.

Q: Does Losacor D affect my potassium levels?

A: Yes, the combination medicine contains two active ingredients that have opposing effects on potassium. Hydrochlorothiazide can lead to low potassium (hypokalemia), while Losartan can cause high potassium (hyperkalemia). For this reason, regulatory guidance recommends periodic monitoring of serum electrolytes (potassium levels) while taking this medicine.

Q: Can I take Losacor D with my cholesterol medicine (statin)?

A: Official drug interaction sections of the regulatory label do not list a specific pharmacological interaction between Losacor D and common statins (cholesterol-lowering medicines). However, both drug classes may be monitored closely in patients with pre-existing liver conditions.

Q: Does Losacor D make me sensitive to the sun?

A: The hydrochlorothiazide component (diuretic) is associated with photosensitivity, which means the skin may be more sensitive to sunlight. The product information advises caution when exposed to the sun and recommends protective measures like sunscreen or clothing.

Q: What should I do if my blood pressure is still high after starting Losacor D?

A: Full blood pressure control is often not achieved immediately and may take between three and six weeks of consistent use. Regulatory advice emphasizes the importance of checking and recording blood pressure readings at home. These records are reviewed by a healthcare provider to assess the drug's effect over the defined time period.

Q: What happens if I stop taking Losacor D suddenly?

A: Stopping this medication suddenly can lead to a rapid increase in blood pressure, which may increase the risk of serious cardiovascular events such as heart attack or stroke. Official guidance highlights that discontinuation of this medication should be overseen by a healthcare professional.

Q: Why did my doctor prescribe Losacor D instead of just Losartan?

A: The product's regulatory indications describe its approved uses. The combination is approved for the treatment of hypertension (high blood pressure). It is also specifically indicated to reduce the risk of stroke in patients who have hypertension with Left Ventricular Hypertrophy (LVH), a finding observed in specific clinical trials.

Q: What should my blood pressure goal be while taking Losacor D?

A: The blood pressure goal for a patient is generally determined based on published clinical practice guidelines from major health organizations, such as the Joint National Committee (JNC). These goals are not set by the drug label itself and can vary based on the individual's overall health profile.

Q: Is there a link between Losacor D and hair loss?

A: Alopecia (hair loss) is listed in official documentation as one of the reported adverse experiences observed in some patients during clinical trials.

Q: Can Losacor D cause stomach upset or nausea?

A: Adverse effects reported in regulatory documents include dyspepsia (stomach discomfort or indigestion), gastritis, and vomiting under the classification of Gastrointestinal Disorders.

Q: Do I have to take Losacor D at a certain time of day?

A: Regulatory guidelines suggest taking the tablet once daily, preferably at the same time each day, to maintain consistent blood levels. Taking the dose at least four hours before bedtime may help to reduce nighttime disruptions due to increased urination from the diuretic component.

Q: What is the difference between Losacor D and other ACE inhibitors?

A: The active ingredient Losartan is classified as an Angiotensin II Receptor Blocker (ARB), which works by blocking specific cell receptors. This is mechanistically different from ACE inhibitors, which work by preventing an enzyme from creating a substance called Angiotensin II.

Q: Can Losacor D interact with herbal supplements?

A: Because Losacor D contains a diuretic, it may interact with herbal supplements that also have a diuretic effect (increase urine output) or that affect potassium levels. Official guidance advises informing a healthcare provider about all prescription, over-the-counter, and herbal products being used.

Q: Is Losacor D used to treat anything besides blood pressure?

A: In addition to treating high blood pressure (hypertension), the combination product is also approved to reduce the risk of stroke in patients who have hypertension along with Left Ventricular Hypertrophy (LVH), a thickening of the heart muscle.

Q: How is Losacor D's effectiveness measured in clinical trials?

A: The drug's effectiveness has been primarily evaluated in clinical trials by monitoring the reduction in blood pressure and the frequency of major cardiovascular events, such as stroke and heart attack.

Q: Is Losacor D a drug that is commonly prescribed?

A: The fixed-dose combination is part of the established therapeutic class of Angiotensin II Receptor Blockers (ARBs) with Diuretics, which is a type of medicine used widely in clinical practice for managing high blood pressure.

Q: Does Losacor D affect my sodium levels?

A: Yes, the hydrochlorothiazide component (diuretic) is described as potentially causing a decrease in sodium levels, a condition known as hyponatremia. For this reason, regulatory guidance recommends periodic monitoring of serum electrolytes.

Q: Is Losacor D a common treatment for enlarged heart?

A: The medicine is indicated to reduce the risk of stroke in patients with hypertension and Left Ventricular Hypertrophy (LVH). LVH refers to a thickening of the heart muscle, and research has specifically monitored changes in this assessment in the studied population.

How to Store and Dispose of Losacor D

Storage of Losartan Potassium and Hydrochlorothiazide tablets (Losacor D) must comply strictly with labeled regulatory conditions to maintain product stability.

Storage Requirements

Losacor D must be stored at Controlled Room Temperature, which is defined as 20 C to 25 C (68 F to 77 F). The medication must be kept in its original container, tightly closed, and protected from both light and excess moisture. Avoid storing the tablets in environments that are subject to freezing temperatures or excessive heat.

Safety and Disposal

It is required to keep this medicine out of the sight and reach of children to prevent accidental ingestion. When disposing of unused or expired Losacor D, follow local regulations. Medicines should not be disposed of in wastewater (flushed down the toilet or poured down the sink) or household trash unless specifically instructed; the preferred method is a formal drug take-back program.